CardioMEMS Implantation Using Gadolinium-based Contrast Agent: A Case Report-Reference-Cited by-同舟云学术

CardioMEMS Implantation Using Gadolinium-based Contrast Agent: A Case Report

Published:2021-04-12 Issue: Volume:7 Page:
ISSN:2057-7559
Container-title:Cardiac Failure Review
language:en
Short-container-title:Card Fail Rev

Author:

Rali Aniket S¹^ORCID,Stevenson Lynne W¹^ORCID,Zalawadiya Sandip K¹

Affiliation:

1. Section of Advanced Heart Failure and Transplant Cardiology, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN, US

Abstract

A 57-year-old woman with New York Heart Association Class III heart failure requiring multiple hospitalisations over the previous year presented for CardioMEMS implantation. Because of the patient’s allergy history of anaphylaxis to iodine-based contrast agent she underwent the device implantation with gadolinium-based contrast agent (Magnevist), which was successful.

Publisher

Radcliffe Group Ltd

Subject

Cardiology and Cardiovascular Medicine

Reference10 articles.

1. Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 2011;377:658–66. https://doi.org/10.1016/S0140-6736(11)60101-3; PMID: 21315441.

2. Shavelle DM, Desai AS, Abraham WT, et al. Lower rates of heart failure and all-cause hospitalizations during pulmonary artery pressure-guided therapy for ambulatory heart failure: one-year outcomes from the CardioMEMS post-approval study. Circ Heart Fail 2020;13:e006863. https://doi.org/10.1161/CIRCHEARTFAILURE.119.006863; PMID: 32757642.

3. Vaduganathan M, DeFilippis EM, Fonarow GC, et al. Postmarketing adverse events related to the CardioMEMS HF system. JAMA Cardiol 2017;2:1277–9. https://doi.org/10.1001/jamacardio.2017.3791; PMID: 28975249.

4. Pradubpongsa P, Dhana N, Jongjarearnprasert K, et al. Adverse reactions to iodinated contrast media: prevalence, risk factors and outcome – the results of a 3-year period. Asian Pac J Allergy Immunol 2013;31:299–306. https://doi.org/10.12932/AP0297.31.4.2013; PMID: 24383973.

5. Rosado IA, Doña Diaz I, Cabañas RM, et al. Clinical practice guidelines for diagnosis and management of hypersensitivity reactions to contrast media. J Investig Allergol Clin Immunol 2016;26:144–55. https://doi.org/10.18176/jiaci.0058; PMID: 27326981.